title: Another clinical evidence straw on the $4 billion ezetimibe camel's back.
authors.affiliation: Washington Hospital Center, Medstar Health Research Institute, Georgetown University, Washington, DC 20010-2975, USA. allen.taylor@medstar.net
authors.forename: Allen J
authors.initials: AJ
authors.lastname: Taylor
mesh_terms: D050197:Atherosclerosis / Q000188:drug therapy*; D001384:Azetidines / Q000008:administration & dosage*; D000069438:Ezetimibe; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D008297:Male; D058729:Peripheral Arterial Disease / Q000188:drug therapy*
chemical_list: D001384:Azetidines; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000069438:Ezetimibe